Prelude Therapeutics Inc at Barclays Global Healthcare Conference Transcript
First and foremost, glad to see everyone in person. This is Barclays Healthcare Global Conference in Miami, so thanks everyone for coming down to Miami in person, first event for 2 years for Wall Street. So we're really excited to get to see everyone again.
And my name is Peter Lawson. I'm one of the biotech analysts at Barclays. Just wanted to thank. We have here with us from Prelude Therapeutics. We have Kris Vaddi, CEO; and Laurent Chardonnet, CFO. And thanks so much for the time. Thanks so much for your support in kind of getting this event back to in person and get us back to seeing each other again.
So I guess first point, we've got -- you've got some slides just to kind of set the scene for us, and then we'll dive into Q&A. Thank you so much.
Thank you, Peter. Thanks for the opportunity to participate in your meeting and we're really excited to be part of -- to be here in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |